Predicting the aerosol performance of dry powder inhalation formulations by interparticulate interaction analysis using inverse gas chromatography

Journal of Pharmaceutical Sciences

Volumn 95, Issue 1, 2006, Pages 228-233

  Tong, Henry H Y ^a   Shekunov, Boris Y ^b   York, Peter ^c   Chow, Albert H L ^d  

^a MACAO POLYTECHNIC INSTITUTE   (Macao)

^b Ferro Corporation   (United States)

^c UNIVERSITY OF BRADFORD   (United Kingdom)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hansen solubility parameters; Interparticulate interactions; Inverse gas chromatography; Salmeterol xinafoate; Supercritical fluid processing

Indexed keywords

LACTOSE; SALMETEROL XINAFOATE; BRONCHODILATING AGENT; DRUG DERIVATIVE; SALBUTAMOL; SALMETEROL;

ADSORPTION; AEROSOL; ARTICLE; CRYSTALLIZATION; DRY POWDER; ENTHALPY; INHALATION; INVERSE GAS CHROMATOGRAPHY; MEASUREMENT; MOLECULAR INTERACTION; SOLID; SOLUBILITY; SUPERCRITICAL FLUID; SURFACE PROPERTY; CHEMISTRY; FORECASTING; GAS CHROMATOGRAPHY; HUMIDITY; INHALATIONAL DRUG ADMINISTRATION; POWDER;

ADMINISTRATION, INHALATION; ADSORPTION; AEROSOLS; ALBUTEROL; BRONCHODILATOR AGENTS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, GAS; FORECASTING; HUMIDITY; LACTOSE; POWDERS; SOLUBILITY;

EID: 33645221184     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20519     Document Type: Article

References (12)

1. Begat P, Morton DAV, Staniforth JN, Price R. 2004. The cohesive-adhesive balances in dry powder inhaler formulations I: Direct quantification by atomic force microscopy. Pharm Res 21:1591-1597.
2. Rowe RC. 1988. Interactions of lubricants with microcrystalline cellulose and anhydrous cellulose-A solubility parameter approach. Int J Pharm 41:223-226.
3. Rowe RC. 1988. Interactions in the ternary powder system microcrystalline cellulose, magnesium stearate and colloidal silica-A solubility parameter approach. Int J Pharm 45:259-261.
4. Rowe RC. 1989. Interactions in coloured powders and tablet formulations: A theoretical approach based on solubility parameters. Int J Pharm 53:47-51.
5. Hancock BC, York P, Rowe RC. 1997. The use of solubility parameters in pharmaceutical dosage form design. Int J Pharm 148:1-21.
6. Tong HHY, Shekunov BY, York P, Chow AHL. 2001. Characterization of two polymorphe of salmeterol xinafoate crystallized from supercritical fluids. Pharm Res 18:852-858.
7. Shekunov BY, Feeley JC, Chow AHL, Tong HHY, York P. 2002. Physical properties of supercritically-processed and micronised powders for respiratory drug delivery. KONA Powder and Particle 20:178-187.
8. Shekunov BY, Feeley JC, Chow AHL, Tong HHY, York P. 2003. Aerosolisation behaviour of micronised and supercritically-processed powders. J Aerosol Sci 34:553-568.
9. Tong HHY, Shekunov BY, York P, Chow AHL. 2002. Influence of polymorphism on the surface energetics of salmeterol xinafoate crystallized from supercritical fluids. Pharm Res 19:640-648.
10. Tong HHY, Shekunov BY, York P, Chow AHL. 2003. Thermal analysis of trace level of polymorphic impurity in salmeterol xinafoate samples. Pharm Res 20:1423-1429.
11. Tong HHY, Shekunov BY, York P, Chow AHL. 2005. Surface characterization of salmeterol xinafoate powders by inverse gas chromatography at finite coverage. J Pharm Sci 94:695-700.
12. Sunkersett MR, Grimsey IM, Doughty SW, Osborn JC, York P, Rowe RC. 2001. The changes in surface energetics with relative humidity of carbamazepine and paracetamol as measured by inverse gas chromatography. Eur J Pharm Sci 13:219-225.